The road to develop domestically produced Merah Putih vaccin

The year 2022 marked a new chapter in the journey of the pharmaceutical industry in the country by showcasing the ability to produce domestic vaccines amid ...

Related Keywords

Airlangga , Jawa Timur , Indonesia , United States , Merah Putih , Sumatera Utara , China , Jember , Gadjah , Surabaya , Jakarta , Jakarta Raya , Bandung , Jawa Barat , Antara , Aceh , Indonesian , Laksana Tri Handoko , Siti Nadia Tarmizi , Fedik Abdul Rantam , Bio Farma , Abogen Yuxi Walvax , Budi Gunadi Sadikin , Joko Widodo , Indonesian Health , University Of Indonesia , Airlangga University , Innovation Agency , Airlangga University Unair , Java Province Natural Resources Quarantine Agency , Head Of The National Research , Pfizer , Public Service Bureau Of The Health Ministry , Indonesian Institute Of Sciences , Baylor College Of Medicine , Bandung Institute Of Technology , Gadjah Mada University , Pt Biotis Pharmaceuticals Indonesia , World Health Organization , Eijkman Molecular Biology Institute , Drug Supervisory Agency , Merah Putih Vaccine Consortium , Airlangga University Hospital Surabaya , Merah Putih Vaccine , Indonesian Institute , Bandung Institute , Viral Like Particle , Good Manufacturing Practices , National Research , Chief Researcher , Baylor College , Pharmaceuticals Indonesia , Java Province , Soetomo Hospital Surabaya , Saiful Anwar Hospital , Lung Hospital , President Joko Widodo , Use Authorization , East Jakarta , Biotechnologies Indonesia , Indonesian Health Minister Budi Gunadi Sadikin , Greater Jakarta , Public Service Bureau , Health Ministry ,